2AnalysisofClinicalTrialsUsingSAS®APracticalGuideSecondEditionEditedbyAlexDmitrienkoGaryG.Koch3Thecorrectbibliographiccitationforthismanualisasfollows:Dmitrienko,Alex,andGaryG.Koch.2017.AnalysisofClinicalTrialsUsingSAS®:APracticalGuide,SecondEdition.Cary,NC:SASInstituteInc.AnalysisofClinicalTrialsUsingSAS®:APracticalGuide,SecondEditionCopyright©2017,SASInstituteInc.,Cary,NC,USAISBN978-1-62959-847-5(Hardcopy)ISBN978-1-63526-144-8(EPUB)ISBN978-1-63526-145-5(MOBI)ISBN978-1-63526-146-2(PDF)AllRightsReserved.ProducedintheUnitedStatesofAmerica.Forahard-copybook:Nopartofthispublicationmaybereproduced,storedinaretrievalsystem,ortransmitted,inanyformorbyanymeans,electronic,mechanical,photocopying,orotherwise,withoutthepriorwrittenpermissionofthepublisher,SASInstituteInc.Forawebdownloadore-book:Youruseofthispublicationshallbegovernedbythetermsestablishedbythevendoratthetimeyouacquirethispublication.Thescanning,uploading,anddistributionofthisbookviatheInternetoranyothermeanswithoutthepermissionofthepublisherisillegalandpunishablebylaw.Pleasepurchaseonlyauthorizedelectroniceditionsanddonotparticipateinorencourageelectronicpiracyofcopyrightedmaterials.Yoursupportofothers’rightsisappreciated.U.S.GovernmentLicenseRights;RestrictedRights:TheSoftwareanditsdocumentationiscommercialcomputersoftwaredevelopedatprivateexpenseandisprovidedwithRESTRICTEDRIGHTStotheUnitedStatesGovernment.Use,duplication,ordisclosureoftheSoftwarebytheUnitedStatesGovernmentissubjecttothelicensetermsofthisAgreementpursuantto,asapplicable,FAR12.212,DFAR227.7202-1(a),DFAR227.7202-3(a),andDFAR227.7202-4,and,totheextentrequiredunderU.S.federallaw,theminimumrestrictedrightsassetoutinFAR52.227-19(DEC2007).IfFAR52.227-19isapplicable,thisprovisionservesasnoticeunderclause(c)thereofandnoothernoticeisrequiredtobeaffixedtotheSoftwareordocumentation.TheGovernment’srightsinSoftwareanddocumentationshallbeonlythosesetforthinthisAgreement.SASInstituteInc.,SASCampusDrive,Cary,NC27513-2414July20174SAS®andallotherSASIn...
